The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Opioid Induced Side Effects Treatment Market Research Report 2025
Synopsis
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group.
The global Opioid Induced Side Effects Treatment market was valued at US$ 1325 million in 2023 and is anticipated to reach US$ 1916.4 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Side Effects Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Side Effects Treatment.
Report Scope
The Opioid Induced Side Effects Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioid Induced Side Effects Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Side Effects Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shionogi
Cubist Pharmaceuticals
SLA Pharma
AstraZeneca
AIKO Biotechnology
Progenics Pharmaceuticals
Segment by Type
Risperidone
Methylphenidate
Cetirizine
Other
Segment by Application
Drug Overdose Treatment
Pain Treatment
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Induced Side Effects Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group.
The global Opioid Induced Side Effects Treatment market was valued at US$ 1325 million in 2023 and is anticipated to reach US$ 1916.4 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Side Effects Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Side Effects Treatment.
Report Scope
The Opioid Induced Side Effects Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioid Induced Side Effects Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Side Effects Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shionogi
Cubist Pharmaceuticals
SLA Pharma
AstraZeneca
AIKO Biotechnology
Progenics Pharmaceuticals
Segment by Type
Risperidone
Methylphenidate
Cetirizine
Other
Segment by Application
Drug Overdose Treatment
Pain Treatment
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Induced Side Effects Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Risperidone
1.2.3 Methylphenidate
1.2.4 Cetirizine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Opioid Induced Side Effects Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Overdose Treatment
1.3.3 Pain Treatment
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Side Effects Treatment Market Perspective (2019-2030)
2.2 Opioid Induced Side Effects Treatment Growth Trends by Region
2.2.1 Global Opioid Induced Side Effects Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Opioid Induced Side Effects Treatment Historic Market Size by Region (2019-2024)
2.2.3 Opioid Induced Side Effects Treatment Forecasted Market Size by Region (2025-2030)
2.3 Opioid Induced Side Effects Treatment Market Dynamics
2.3.1 Opioid Induced Side Effects Treatment Industry Trends
2.3.2 Opioid Induced Side Effects Treatment Market Drivers
2.3.3 Opioid Induced Side Effects Treatment Market Challenges
2.3.4 Opioid Induced Side Effects Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Side Effects Treatment Players by Revenue
3.1.1 Global Top Opioid Induced Side Effects Treatment Players by Revenue (2019-2024)
3.1.2 Global Opioid Induced Side Effects Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Opioid Induced Side Effects Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid Induced Side Effects Treatment Revenue
3.4 Global Opioid Induced Side Effects Treatment Market Concentration Ratio
3.4.1 Global Opioid Induced Side Effects Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Side Effects Treatment Revenue in 2023
3.5 Opioid Induced Side Effects Treatment Key Players Head office and Area Served
3.6 Key Players Opioid Induced Side Effects Treatment Product Solution and Service
3.7 Date of Enter into Opioid Induced Side Effects Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Induced Side Effects Treatment Breakdown Data by Type
4.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Type (2019-2024)
4.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2025-2030)
5 Opioid Induced Side Effects Treatment Breakdown Data by Application
5.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Application (2019-2024)
5.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Opioid Induced Side Effects Treatment Market Size (2019-2030)
6.2 North America Opioid Induced Side Effects Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
6.4 North America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid Induced Side Effects Treatment Market Size (2019-2030)
7.2 Europe Opioid Induced Side Effects Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
7.4 Europe Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size (2019-2030)
8.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioid Induced Side Effects Treatment Market Size (2019-2030)
9.2 Latin America Opioid Induced Side Effects Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
9.4 Latin America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size (2019-2030)
10.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shionogi
11.1.1 Shionogi Company Detail
11.1.2 Shionogi Business Overview
11.1.3 Shionogi Opioid Induced Side Effects Treatment Introduction
11.1.4 Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.1.5 Shionogi Recent Development
11.2 Cubist Pharmaceuticals
11.2.1 Cubist Pharmaceuticals Company Detail
11.2.2 Cubist Pharmaceuticals Business Overview
11.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Introduction
11.2.4 Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.2.5 Cubist Pharmaceuticals Recent Development
11.3 SLA Pharma
11.3.1 SLA Pharma Company Detail
11.3.2 SLA Pharma Business Overview
11.3.3 SLA Pharma Opioid Induced Side Effects Treatment Introduction
11.3.4 SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.3.5 SLA Pharma Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Opioid Induced Side Effects Treatment Introduction
11.4.4 AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.4.5 AstraZeneca Recent Development
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Detail
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.5.5 AIKO Biotechnology Recent Development
11.6 Progenics Pharmaceuticals
11.6.1 Progenics Pharmaceuticals Company Detail
11.6.2 Progenics Pharmaceuticals Business Overview
11.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Introduction
11.6.4 Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.6.5 Progenics Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
